Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NPS Pharma says FDA advisors will review the company's bowel drug Gattex
NPS Pharma says FDA advisors will review the company's bowel drug Gattex
NPS Pharma says FDA advisors will review the company's bowel drug Gattex
Submitted by
admin
on August 21, 2012 - 12:20pm
Source:
Yahoo/AP
News Tags:
FDA
NPS Pharmaceuticals
Gattex
short bowel syndrome
Headline:
NPS Pharma says FDA advisors will review the company's bowel drug Gattex
Do Not Allow Advertisers to Use My Personal information
